ProGene Biomedical - Crunchbase Company Profile & Funding

Q: Who invested in ProGene Biomedical?

ProGene Biomedical is funded by Ampersand Capital Partners.

Q: How much funding has ProGene Biomedical raised to date?

ProGene Biomedical has raised obfuscated.

Overview

ProGene Biomedical

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About ProGene Biomedical

ProGene Biomedical is a clinical reference laboratory specializing in clinical immunology and allergy testing.

Closed

Founded

obfuscation

Private

Venture - Series Unknown

Lenexa, Kansas, United States

www.ibtreflab.com/

Biotechnology

Health Care

Life Science

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Details

Legal Name

PROGENE BIOMEDICAL, INCORPORATED

Operating Status

Closed

Company Type

For Profit

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - ProGene Biomedical	1	obfuscated obfuscation	Ampersand Capital Partners	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Ampersand Capital Partners	Yes	Venture Round - ProGene Biomedical	David Parker, Herbert Hooper
Ampersand Capital Partners	Yes	Venture Round - ProGene Biomedical	David Parker, Herbert Hooper
Ampersand Capital Partners	Yes	Venture Round - ProGene Biomedical	David Parker, Herbert Hooper
Ampersand Capital Partners	Yes	Venture Round - ProGene Biomedical	David Parker, Herbert Hooper
Ampersand Capital Partners	Yes	Venture Round - ProGene Biomedical	David Parker, Herbert Hooper